Publicaciones en las que colabora con FRANCISCO JAVIER LÓPEZ LONGO (9)

2022

  1. Long-Term Retention Rate of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting

    Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E150-E155

2018

  1. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 88-93

  2. Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren’s syndrome

    Journal of International Medical Research, Vol. 48, Núm. 1

2016

  1. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?

    Rheumatology International, Vol. 36, Núm. 6, pp. 793-797

2001

  1. Erratum: Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies (European Journal of Nuclear Medicine (1768))

    European Journal of Nuclear Medicine

2000

  1. Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies

    European Journal of Nuclear Medicine, Vol. 27, Núm. 12, pp. 1768-1773

  2. Juvenile chronic arthritis

    Revista clínica española, Vol. 200 Monog 1, pp. 64-68

1997

  1. Expresión clínica del lupus eritematoso sistémico con anticuerpos anti-U1-RNP y anti-Sm

    Revista Clinica Espanola, Vol. 197, Núm. 5, pp. 329-335

1996

  1. Coexistencia de anticuerpos anti-52 KD, anti-La/SSB y anticuerpos anti-Ro/SSA 60 KD en las enfermedades sistémicas autoinmunes

    Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales, Vol. 90, Núm. 1, pp. 43-48